Christopher Oakes, PhD
College of Medicine
Dr. Oakes’ current research focuses on investigating the role of epigenetics in hematological malignancies, with a primary focus on understanding the evolution and impact of epigenetic programming on the cancer cell phenotype. As the mechanisms that promote changes to the tumor epigenome are undefined, his lab endeavors to uncover the impact that developmental programs and somatic alterations have on the coevolution and selection of novel epigenetic patterns. He is interested in the developmental origins of epigenetic programming in lymphoid and myeloid malignancies and aim to uncover the ontogeny of disease development. Clinical applications of disease stratification, drug response prediction and novel therapeutic targets are current avenues of exploration.